Sima Rozati

1.1k total citations
36 papers, 532 citations indexed

About

Sima Rozati is a scholar working on Dermatology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Sima Rozati has authored 36 papers receiving a total of 532 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Dermatology, 18 papers in Oncology and 17 papers in Pathology and Forensic Medicine. Recurrent topics in Sima Rozati's work include Cutaneous lymphoproliferative disorders research (22 papers), Lymphoma Diagnosis and Treatment (15 papers) and CAR-T cell therapy research (9 papers). Sima Rozati is often cited by papers focused on Cutaneous lymphoproliferative disorders research (22 papers), Lymphoma Diagnosis and Treatment (15 papers) and CAR-T cell therapy research (9 papers). Sima Rozati collaborates with scholars based in United States, Switzerland and United Kingdom. Sima Rozati's co-authors include Reinhard Dummer, Simone M. Goldinger, Mitchell P. Levesque, Lars E. French, Katrin Kerl, Youn H. Kim, Daniel Widmer, Uma Sundram, Mahkam Tavallaee and Seema Nagpal and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Sima Rozati

33 papers receiving 525 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sima Rozati United States 12 327 232 220 151 148 36 532
Shanta Chawla United States 7 173 0.5× 336 1.4× 290 1.3× 330 2.2× 205 1.4× 15 702
Salvia Jain United States 11 93 0.3× 151 0.7× 172 0.8× 201 1.3× 204 1.4× 44 487
Aishwarya Iyer Canada 8 145 0.4× 127 0.5× 109 0.5× 109 0.7× 75 0.5× 22 323
A. Appino Italy 10 190 0.6× 92 0.4× 82 0.4× 40 0.3× 112 0.8× 14 311
Alan Siroy United States 10 86 0.3× 50 0.2× 213 1.0× 198 1.3× 70 0.5× 19 408
Britta Lamottke Germany 7 45 0.1× 105 0.5× 151 0.7× 300 2.0× 55 0.4× 8 420
M Wasik Poland 5 78 0.2× 114 0.5× 181 0.8× 109 0.7× 165 1.1× 11 341
Dejan Radeski Australia 9 30 0.1× 98 0.4× 140 0.6× 164 1.1× 45 0.3× 20 307
H. Cazenave France 3 51 0.2× 25 0.1× 443 2.0× 127 0.8× 160 1.1× 4 520
Naima Benannoune France 2 49 0.1× 25 0.1× 441 2.0× 127 0.8× 159 1.1× 6 517

Countries citing papers authored by Sima Rozati

Since Specialization
Citations

This map shows the geographic impact of Sima Rozati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sima Rozati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sima Rozati more than expected).

Fields of papers citing papers by Sima Rozati

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sima Rozati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sima Rozati. The network helps show where Sima Rozati may publish in the future.

Co-authorship network of co-authors of Sima Rozati

This figure shows the co-authorship network connecting the top 25 collaborators of Sima Rozati. A scholar is included among the top collaborators of Sima Rozati based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sima Rozati. Sima Rozati is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gordon, Emily R., Megan H. Trager, Connor J. Stonesifer, et al.. (2024). Maintenance therapy for CTCL: importance for prevention of disease progression. Leukemia & lymphoma. 65(12). 1883–1890.
2.
Paul, Suman, et al.. (2024). Antibody-Based Therapies for Peripheral T-Cell Lymphoma. Cancers. 16(20). 3489–3489. 1 indexed citations
3.
Lemaître, C., Ziyi Wang, Antonio M. Lacy, et al.. (2024). 229 Development of supervised and unsupervised machine learning models to differentiate cutaneous syndromes in post-stem cell transplant patients. Journal of Investigative Dermatology. 144(8). S40–S40. 1 indexed citations
4.
Kumar, Priyanka, et al.. (2023). Association of Cardiovascular Disease in Patients with Mycosis Fungoides and Sézary Syndrome Compared to a Matched Control Cohort. SHILAP Revista de lepidopterología. 3(6). 100219–100219. 1 indexed citations
5.
Weiner, David M., et al.. (2023). Oral Mucosal Pigmentation in a Patient With Mycosis Fungoides. JAMA Oncology. 9(10). 1455–1455.
6.
Geskin, Larisa J., Oleg E. Akilov, Paula Enz, et al.. (2022). International Society for Cutaneous Lymphomas Pandemic Section (ICLYPS) analysis of cutaneous T-cell lymphoma outcomes during the COVID-19 pandemic: A retrospective cohort study. Journal of the American Academy of Dermatology. 88(4). 935–937. 2 indexed citations
7.
Marchitto, Mark, Isabelle Brown, Jaroslaw Jedrych, & Sima Rozati. (2022). Heliotrope Rash, Gottron Papules, and Ragged Cuticles in Darker Skin. The American Journal of Medicine. 136(1). 54–56. 1 indexed citations
8.
Marchitto, Mark, et al.. (2021). Artifactual pseudo-cheilitis: A case series of an underreported condition. JAAD Case Reports. 17. 111–115. 3 indexed citations
9.
Rozati, Sima, et al.. (2020). Disseminated Eruptive Blue Nevi in a Young Adult Patient. Cureus. 12(11). e11298–e11298. 1 indexed citations
10.
Shanbhag, Satish, et al.. (2020). Update on Biology of Cutaneous T-Cell Lymphoma. Frontiers in Oncology. 10. 765–765. 21 indexed citations
11.
Rozati, Sima & Youn H. Kim. (2016). Experimental treatment strategies in primary cutaneous T-cell lymphomas. Current Opinion in Oncology. 28(2). 166–171. 3 indexed citations
12.
Mangana, Joanna, Phil F. Cheng, Katja Schindler, et al.. (2015). Analysis of BRAF and NRAS Mutation Status in Advanced Melanoma Patients Treated with Anti-CTLA-4 Antibodies: Association with Overall Survival?. PLoS ONE. 10(10). e0139438–e0139438. 26 indexed citations
13.
14.
Guenova, Emmanuella, Wolfram Hoetzenecker, Sima Rozati, et al.. (2014). Novel therapies for cutaneous T-cell lymphoma: what does the future hold?. Expert Opinion on Investigational Drugs. 23(4). 457–467. 25 indexed citations
15.
Felderer, Lea, et al.. (2013). Basal cell carcinoma: a paradigm for targeted therapies. Expert Opinion on Pharmacotherapy. 14(10). 1307–1318. 11 indexed citations
16.
Rinderknecht, Jeannine D., Simone M. Goldinger, Sima Rozati, et al.. (2013). RASopathic Skin Eruptions during Vemurafenib Therapy. PLoS ONE. 8(3). e58721–e58721. 59 indexed citations
17.
Mangana, Joanna, Simone M. Goldinger, Katja Schindler, et al.. (2013). Analysis of BRAF and NRAS mutation status in advanced melanoma patients treated with anti-CTLA-4 antibodies: Association with overall survival?. Journal of Clinical Oncology. 31(15_suppl). 9025–9025. 5 indexed citations
18.
Belloni, Benedetta, Nicola Schönewolf, Sima Rozati, Simone M. Goldinger, & Reinhard Dummer. (2012). Cutaneous Drug Eruptions Associated with the Use of New Oncological Drugs. Chemical immunology/Fortschritte der Allergielehre/Progress in allergy/Chemical immunology and allergy. 97. 191–202. 15 indexed citations
19.
Dummer, Reinhard, Sima Rozati, N. Eggmann, Jeannine D. Rinderknecht, & Simone M. Goldinger. (2012). From chemotherapy to targeted treatment. Annals of Oncology. 23. x101–x103. 4 indexed citations
20.
Rozati, Sima, et al.. (2012). Real-life Experience With Pegylated Interferon and Conventional Interferon in Adjuvant Melanoma Therapy. Journal of Immunotherapy. 36(1). 52–56. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shanta Chawla Breakdown of academic impact, for papers by Salvia Jain Breakdown of academic impact, for papers by Aishwarya Iyer Breakdown of academic impact, for papers by A. Appino Breakdown of academic impact, for papers by Alan Siroy Breakdown of academic impact, for papers by Britta Lamottke Breakdown of academic impact, for papers by M Wasik Breakdown of academic impact, for papers by Dejan Radeski Breakdown of academic impact, for papers by H. Cazenave Breakdown of academic impact, for papers by Naima Benannoune
Rankless by CCL
2026